ea0086p269 | Reproductive Endocrinology | SFEBES2022
Owen Manon
, Hugh Katie
, Quilang Rachel
, Scott Eleanor
, Forbes Karen
Metformin is a first-line therapy for type-2 diabetes mellitus and gestational diabetes mellitus (GDM) which shows significant benefits for maternal health. However, offspring exposed to metformin in-utero have an increased risk of being born small for gestational age and developing cardiometabolic complications in adulthood. The mechanisms responsible are unknown. As fetal growth is dependent on optimal placental function, we assessed whether metformin exposure alter...